This wide ranging discussion, sponsored by our Paris office, focuses on navigating cross border collaborations, insights for entering the US life sciences market as well as strategies for capitalizing on the growth of digital health. We will be joined by key players from the life sciences community, including life sciences companies, advisers and industry experts to discuss the latest trends, opportunities and developments in the life sciences industry.

Please find below a brief overview of the sessions;

• Cross border licensing and collaboration agreements
• Cross border financing and investments
• US market entry (FDA, reimbursement and setting up a US entity)
• Digital Health